TG Therapeutics | Passivo Circulante



Current Liabilities Alterar Data
AbbVie USD 38.75B 4.31B 2024-12
Alaunos Therapeutics USD 4K 822K 2024-10
Amgen USD 23.1B 2.79B 2024-12
Ardelyx USD 77.83M 7.33M 2024-12
Arrowhead Research USD 93.76M 9.41M 2024-12
Bayer EUR 28.95B 3.9B 2024-12
Biogen USD 5.53B 103.8M 2024-12
Corcept Therapeutics USD 140.77M 14.56M 2024-12
Dynavax Technologies USD 78.63M 8.6M 2024-12
Gilead Sciences USD 12B 279M 2024-12
J&J USD 50.32B 1.44B 2024-12
Novartis USD 28.69B 560M 2024-12
PTC Therapeutics USD 580.98M 29.73M 2024-12
Regeneron Pharmaceuticals USD 5.7B 2.04B 2024-12
Roche Holding CHF 27.02B 424M 2024-12
TG Therapeutics USD 90.68M 34.43M 2024-12
Vertex Pharmaceuticals USD 3.56B 408.5M 2024-12



TG Therapeutics Passivo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Apr 2025.